News
The Nutraceutical Packaging Market is witnessing steady growth driven by rising health awareness and demand for functional foods. Key players such as ...
Driven by self-medication trends, health-conscious consumers, and innovative formulations, the OTC drugs market thrives on the widespread availabilit ...
A part-time MBA student reflects on how attending the 2025 India Business Conference highlighted the country’s growing global ...
The Asia Pacific healthcare augmented reality (AR) and virtual reality (VR) market is set to grow significantly, with an anticipated annual growth rate of 36.2%, reaching a total market cap of $70.15 ...
The global healthcare AR and VR market is expected to reach $64.87 billion by 2032, growing at an annual rate of 33.7% from 2022 to 2032. This growth is driven by the increasing adoption of advanced ...
Practo, an Indian healthcare services platform connecting doctors and patients, wants to double its revenue from international business in the next three years as it expands into developed markets, a ...
Thwarted in her ambition to become a brewmaster, Kiran Mazumdar-Shaw channeled her frustrations into building a knockoff drug ...
India's pharmaceutical industry is a global giant ranking third in volume and 14th in value. It's the largest supplier of generic medicines providing 20 per cent of the world's supply and a key player ...
The Indian Pharmaceutical Alliance (IPA) will host the 10th Global Pharmaceutical Quality Summit (GPQS) on February 27-28, 2025, at the J.W. Marriott Juhu in Mumbai. With the theme "Navigating the ...
"The Indian pharmaceutical industry plays a vital role in ensuring access to affordable, quality-assured medicines in the US,” says Sudarshan Jain, secretary general, Indian Pharmaceutical ...
While the impact on Indian semiconductor sector is expected to be negligible as the industry is still at a nascent stage, the tariffs could inflict pain on pharma firms for whom the US is the ...
As Novartis navigates the complex landscape of the pharmaceutical industry, it faces both significant opportunities and challenges that warrant a closer examination. Novartis has established ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results